Poor performance of the total kappa/lambda light chain quantification in the diagnosis and follow-up of patients with multiple m
![Frontiers | Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy Frontiers | Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy](https://www.frontiersin.org/files/Articles/697876/fcimb-11-697876-HTML/image_m/fcimb-11-697876-g001.jpg)
Frontiers | Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy
![PDF) Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies PDF) Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies](https://www.researchgate.net/publication/292707470/figure/fig4/AS:669620646187022@1536661411380/Measurement-of-kappa-and-lambda-light-chains-in-free-and-total-assays-Total-light_Q320.jpg)